As of Nov 24
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 92.00, with a high estimate of 97.00 and a low estimate of 84.00. The median estimate represents a +10.38% increase from the last price of 83.35.
The current consensus among 4 polled investment analysts is to Buy stock in Magellan Health Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.